Valuation : Procter & Gamble Health Limited

Market Cap 94.18B 996M 856M 806M 735M 1.38B 1.38B 9.55B 3.69B 48.23B 3.74B 3.66B 154B P/E 2027 *
25.6x
P/E 2028 * 23.1x
Enterprise Value 94.18B 996M 856M 806M 735M 1.38B 1.38B 9.55B 3.69B 48.23B 3.74B 3.66B 154B EV / Sales 2027 *
6.09x
EV / Sales 2028 * 5.4x
Free-Float
47.81%
Yield 2027 *
1.92%
Yield 2028 * 2.08%
1 day-1.13%
1 week-2.99%
Current month-2.62%
1 month-5.96%
3 months-9.54%
6 months+16.03%
Current year-1.60%
1 week 5,585
Extreme 5585
5,770
1 month 5,585
Extreme 5585
6,165
Current year 4,699.7
Extreme 4699.7
6,955
1 year 4,699.7
Extreme 4699.7
6,955
3 years 4,640.3
Extreme 4640.3
6,955
5 years 3,883
Extreme 3883
6,955
10 years 681
Extreme 681
7,499.95
Manager TitleAgeSince
Chief Executive Officer 57 01/04/2018
Director of Finance/CFO - 01/10/2025
Chief Tech/Sci/R&D Officer - 01/09/2025
Director TitleAgeSince
Director/Board Member 57 01/04/2018
Director/Board Member 51 01/06/2019
Chairman 69 01/04/2025
Change 5-day change 1-year change 3-year change Capi.($)
-1.13%-2.99%-14.04%+11.06% 996M
-0.48%-2.23%+19.29%+66.83% 48.08B
+0.60%-4.76%+39.20%+117.99% 39.95B
-0.79%-2.74%-10.20%+11.20% 11.92B
-0.99%-1.91%+13.46%+82.36% 12.2B
-1.50%-0.38%+24.76%+138.18% 9.22B
+0.16%-2.90%+22.64%+35.50% 7.41B
+0.25%-2.45%+36.48%-13.41% 7.37B
+0.92%+0.17%+20.60%+218.53% 7.32B
-0.32%-1.85%-46.31%+22.01% 5.17B
Average -0.33%-2.00%+10.59%+69.03% 14.96B
Weighted average by Cap. -0.18%-3.10%+20.70%+81.72%

Financials

2027 *2028 *
Net sales 15.47B 164M 141M 132M 121M 226M 227M 1.57B 607M 7.92B 614M 601M 25.24B 17.43B 184M 159M 149M 136M 255M 255M 1.77B 683M 8.93B 692M 677M 28.44B
Net income 3.67B 38.82M 33.39M 31.4M 28.66M 53.61M 53.78M 372M 144M 1.88B 146M 143M 5.99B 4.09B 43.21M 37.16M 34.95M 31.91M 59.68M 59.87M 414M 160M 2.09B 162M 159M 6.67B
Net Debt - -
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,276
Date Price Change Volume
08/09/26 5,609.75 -1.13% 318
07/09/26 ₹5,673.90 +0.28% 354
04/09/26 ₹5,657.90 -1.81% 618
03/09/26 ₹5,762.20 +1.46% 353
02/09/26 ₹5,679.10 -1.79% 189
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGHL Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!